two received two intravenous doses of each narcotic administered 60 minutes apart: morphine I and 2 rag. kg -L, fentanyl 0.01 and 0.02 rag. kg -~ and meperidine IO and 20 rag. kg -~, also with an in-.spired gas mixture of nitrous oxide 50 pet" cent with oxygen. Both groups .eceived intravenous pancuronium 0.2 rag, kg-L Each animal in Group I or Group 2 was studied three times, but only once a week and one anaesthetic regimen per study. The order of administration of the anaesthetic regimen was randomized for both groups.
Lead II of the electrocardiogram, oesophageal temperature and arterial pressure were monitored continuously. Oesophageal temperature was maintained at 37 +_ I ~ C throughout the study. Heating pads were used when necessary. The arterial pressure was taken from a two-inch catheter inserted percutaneously into the femoral artery fi'om which blood gases and serum sodium (Na) and potassium (K) were determined before epinephrine infusion when the preparation was stabilized, during the peak pressure response fi-om epinephrine infusion and every 30 minutes for the ~'est of the experiment. Five per cent dextrose in lactated Ringer's solution was infused to maintain a mean arterial pressure of 10.66 + 1,33 kPa (80 • 10 torr) during the anaesthetic course. This varied from 7 to 22 ml/kg with a mean of 12 ml/kg. When the preparation became stable in 30-45 minutes, epinephrine 5 ~g/ml was infused at a rate of I tag-kg -m -rain -~ up to ten minutes, with a Harvard syringe pump. in eight of 24 experiments in Group I the epinephrine infusion was stopped after about five minutes because of the development of ventricular tachycardia (VT) or ventrieular fibrillation (VF). All but one of the 48 epinephrine infusions in Group 2 went to completion with a total of |0 lag' kg -~' min-~~ (see RESULTS). The occurrence of three or more consecutive dysrhythmic beats was used as the endpoint of the epinephrine arrhythmogenic dose.
Statistical comparisons were made using the Student's t-test for paired and unpaired data. P values less than 0.05 were considered significant.
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RESULTS
The peak mean arterial blood pressure increases from epinephrine infusion in all treatment groups varied from 6.6-10.66 kPa (50-80 torr) and were not significantly different among groups. However, the mean arterial blood pressures of animals anaesthetized with meperidinenitrous oxide-pancuronium, before epinephrine infusion, were generally 1,33-4.0 kPa (I0-30 ton') lower than the animals anaesthetized by the other regimen; Iherefore, larger quantities ( 15-20 ml/kg) of 5 per cent dextrose in lactated Ringer's solution were infused to maintain the mean arterial pressure of 10.66 kPa (80 tort).
Arterial blood gases showed minimal changes in both groups, and there were no significant differences among groups during the course of the experiment. The pooled values (N = 216, mean + S D) were Pao= 24 _ 2.13 kPa ( 180-t" 16 ton), Paco2 4.8 4-0.4 kPa (36 _ 3 torr) and cH + 43.65 4-0.14 nmol/I (pH 7.36_ 0,07). Control serum sodium was [42 4-5 mmol/I and serum potassium was 4. I _+ 0.3 mmol/I. Serum sodium did not change significantly during the course of the experiments, but serum potassium increased to a peak concentration of 6.5 -0,4 mmol/I at 4.3 _ 1.2 minutes following the infusion of epinephrine (4.3 4-0.9 pg-kg-t). The peak serum potassium changes were not significantly different among groups during the epinephrine infusion.
The dose of epinephrine that induced dysrhythmias during narcotic-nitrous oxide anaesthesia is summarized in Table I . The arrhythmogenic dose tended to be higher for morphine in comparison with fentanyl or meperidine, but not statistically significant. We were not able to demonstrate a dose-response relationship at the doses studied. The ventricular dysrhythmia dose was generally higher than the corresponding supraventdcular dose for each anaesthetic regimen. Out of 48 epinephrine challenges in the eight dogs anaesthetized with narcotics and nitrous oxide ventricuhw tachycardia was observed only once during fentanyl-nitrous oxide anaesthesia ( Table  !) .
The dose of epinephrine that induced dysrhythmias during anaesthesia with the halogenated agents and nitrous oxide is summarized in Table II . There was no significant difference between the arrhythmogenic doses among the halogenated agents studied. The ventricular dysrhythmic doses were generai|y higher than their corresponding supraventricular dysrhythmic doses during the same anaesthetic regimen. The incidence of ventricular dysrhythmias was less during methoxyflurane-nilrous oxide anaesthesia (4/8) Ihan with halothane-nitrous oxide (8/8) and enflurane-nitrous oxide (8/8) anaesthesia (Table  ll) . The ventricular dysrhythmias observed during halothane-nitrous oxide or enflurane-nitrous oxide anaesthesia were multifocal and associated with bigeminy to quadrageminy, whereas those observed during methoxyflurane-nitrous oxide were usually unifocal dispersed with bigeminy only. The arrhythmogenic doses in the halogenated anaesthesia groups were significantly higher than in the narcotic anaesthesia groups; however, the incidence of ventricula,-dysrhythmias was greater in the halogenated anaesthesia groups (20/24 vs 20/48). Ventricular tachycardia and/or ventricular fibrillation occu,'red in five out of eight epinephrine challenges in the halothane group, three out of eight in the enflurane group and in none of the eight in the methoxyflurane-nitrous oxide group (Table I l).
DISCUSSION
Intravenous epinephrine was first used as a method of inducing cardiac dysrhythmias in dogs in the classic publication of Meek, e/al. in 1937. L More recently, others have used the appearance of veml'ieular extrasystoles as the end point following incremental doses of epinephrine.-"~ The use of epinephrine for evaluating the arrhythmogen[c potential of anaesthetics is clinically meaningful because intraoperativr cardiac dysrhythmias are fi'equently associated with imbalance of the autonomic nervous system, usually at preponderance of sympathetic activity, and epinephrine is still commonly used Io reduce surgical bleeding.
Factors s which are known to potentiate catecholamine-induced cardiac dysrhythmias are hypoxia, hypercarbla, hypertension and electrolyte imbalance, especially hyper-or hypokalaemia, v The arterial blood gases obtained during this study would tend to eliminate hypoxia and hypercarbia as contributing factors. Hypertension during epinephrine infusion was not controlled in our study, but blood pressure elevations were not significantly different among the groups, The combination of meperidine and nitrous oxide tended to be more hypotensive than the other anaesthetic regimen in the dog, but the hypotension was easily overcome by intravascular infusion. Once stabilized, the blood pressure of all animals was well maintained throughout the experimental period. Epinephrine is known to re- 
Mean _+ SD (N = 8); numbers in parentheses represent incidence of occurrence. *Significantly larger (P < 0,05) than the corresponding doses required to produce supraventricular dysrhythmlas. Ventricular dysrhythmias are usually unifncal, not associated with bigeminy, and without pulse deficits. Mean + SD (N = 8); numbers in parentheses represent incidence of occurrence. None of the arrhythmogenic doses are significantly different from each other (P > 0.05). but they are larger (P < 0.05) than the corresponding sapraventricular and ventricular doses of Table 1 ; ventricular dysrhythmias are frequently multifoeal and associated with bigeminy to quadrageminy with pulse deficits, lease endogenous potassium from the liver, s and cardiac dysrhythmias are potentiated by hyperkalaemia. 5 A mean peak serum potassium concentration of 6.5 mmol/I was obtained in this study following epinephrine infusion. None of the serum potassium measurements were higher than 7.0 mmol/I in any group. It has been reported that serum potassium between 6-9 mmolll is a cardiac stimulant 9"~~ and would exert an insignificant dysrhythmic effect on the heart below 6 mmol/I, Therefore, changes in serum potassium among groups in this study do not appear to be an influential factor in the genesis of dysrhythmias induced by epinephrine.
In a preliminary report where halothane, enflurane, fluroxene and methoxyflurane were studied with nitrous oxide and oxygen or nitrogen ~md oxygen as inspired gas mixtures, the data suggested that the addition of nitrous oxide to the halogenated anaesthetics was more arrhythmogenic than the addition of nitrogen during epinephrine-induced ventricular dysrhythrains. 7 The present study did not demonstrate significant differences of the arrhythmogenic doses among the halogenated-nitrous oxide anaesthetics (Table 1I ). This lack of arrhythmic dose differences among halothane, enflurane and methoxyflurane is different from published reports. ~'* However, it should be noted that all of these published studies were done without the addition of nitrous oxide. The addition of nitrous oxide to these halogenated general anaesthetics significantly decreased the arrhythmogenic dose of epinephrine in this study as compared with the previous studies, 2-4 Nitrous oxide is known to have an a-adrenergic stimulating action when administered with oxygen. ~1.~ 2 This a-adrenergic stimulating action of nitrous oxide is also evident when administered with other inhalation anaesthetics tJ-ts or morphine. 16 However, whereas morphine-oxygen produced cardiac stimulation, the addition of nitrous oxide to morphine-oxygen produced cardiac depression. 16 Pancuronium has also been shown to have a vagolytic effect on the heart in animals t7 and cardiovascular stimulating effects in man, ~s The interaction of nitrous oxide with the anaesthetics or narcotics is not well understood and is probably more complex with the addition of pancuronium. Failure to demonstrate different arrhythmic potentials of the haloge-naled agents to epinephrine infusion may be related to the addition of nitrous oxide and pancuronium. Methoxyflurane-nilrous oxide anaesthesia was not only associated with a lower incidence of ventricular dysrhythmias (4/8) in comparison with halothane-nitrous oxide (8/8) and enflurane-nitrous oxide (8]8). but also was not associated with any occurrence of ventricular tachycardia or ventricular fibrillation. When methoxyflurane was administered without the addition of nitrous oxide to dogs 2 and goats, 4 the arrhythmic doses of epinephrine were higher than those required during halothane anaesthesia, but the same as those required during enflurane anaesthesia. Melhoxyflurane and enflurane are both ether derivatives and possess pharmacological actions similar to diethyl ether, which has potent cardiac stabilizing qualities against epinephrine-induced dysrhythmias.~ The addition of nitrous oxide appears to antagonize the cardiac stabilizing effects of enflurane more them of methoxyflurane. Meihoxyflurane with nitrous oxide has been advocated for anaesthetic management of phaeochromocytoma, ~9 where epinephrine-induced ventricular arrhythmias are a problem. In the present study, methoxyflurane-nitrous oxide anaesthesia was as effective us narcotic-nitrous oxide anaesthesia in preventing the occurrence of ventricular tachycardia and ventricular fibrillation.
The narcotic doses used in Ihis study were aimed at meaningful doses for clinical anaesthesia and represent equipotent doses of morphine, fentanyl and meperidine, There are no published data on the "MAC" of narcotics. The preliminary report of Fraiolio et al. tend to suggest theft I rag-kg -I of morphine sulfate and 60 per cent nitrous oxide are required to prevent movement of 50 per cent of patient in response to a skin incision; this is defined as the 0.5 MAC equivalent of morphine. 2~ The lack of doseresponse relationship in the present study would suggest that the doses chosen were on the nearly flat portion of the dose-response curve. The complex interaction of nitrous oxide, pancuronium and narcotics noted above could also have influenced the results. T~ 0~s consistently required sma!lerdoses ~ne_ to induce cardiac dysrh ty!l~ as compared with the halogen_ate-d-nitrous oxide gl'oUES, which was an unexpected findinQ: However, the ventricular dysr71ythmias observed in the halogenated anaesthesia group were frequently multifocal with" bigeminy to quadrageminy, with greater distortion of the QRS complexes and with pulse deficits (Figure I ). This type of rhythm led to more frequent ventricular tachycardia or fibrillation except during methoxyflurane-nitrous oxide anaesthesia. In contrast, the venlricular dysrhylhmias of the narcotic groups were of slower heart rate, with less distortion of the QRS complexes and without pulse deficits (Figure l) . The latter type of rhythm rarely led to ventricular tachycardia or ventricular fibrillation. The onset of ventricula=" dysrhythmias in the narcotic-nitrous oxide group was not usually preceded by bradycardia; whereas those observed in the halogenatednitrous oxide groups were usually preceded by bradycardia. Since there was no significant difference in peak blood pressure between the two groups, these findings tend to suggest that reflex bradycardia was blocked by narcotics with nitrous oxide, but not blocked by halogenated anaesthetic agents with nitrous oxide. Suppression of supraventricular pacemakers with bradycardia allows emergence of ventricular pacemakers. ]t is possible that anaesthesia with halothane or enflurane and nitrous oxide may also produce intrinsic ventricular conduction defects that potentiate ventricular dysrhythmias during epinephrine infusion. That larger doses of epinephrine are required before the onset ofventricular dysrhythmias in the halogenated nit='ous oxide groups may possibly explain the increased incidence of ventricular tachycardia and ventricuiar fibrillation when they occurred. These results suggest that anaesthesia with narcotics or methoxyflurane, nitrous oxide and relaxants may PUERTO, el (t/.: EPINEPHRINE-INDUCED DYSRHYTHMIAS stabilize the heart against serious epinephrineinduced ventricular dysrhythmias better than anaesthesia with halothane or enflu,ane with nitrous oxide and relaxant.
SUMMARY
The effects of epinephrine-induced dysrhythmias were evaluated in sixteen 15-20 kg mongrel dogs anaesthetized with halogenated inhalation agents, nitrous oxide and pancuronium and with narcotics, nitrous oxide and pancuronium. Group I consisted of eight animals which received 1.2 MAC halotliane, enflurane or methoxyflurane in nitrous oxide and oxygen (2.5/2.5 litres) and Group 2 of eight animals which received morphine (l and 2mg.kg-~), fentanyl (0.01 and 0,02 mg-kg -I) and meperidine (10 and 20mg.kg -t) with nitrous oxide and oxygen (2.5f2.5 litres). Pancuronium (0.2 mg-kg -I) was administered to both groups. Each animal in Group 1 or 2 was studied three times but only once a week and one anaesthetic regimen per study. The order of administration of the anaesthetic regimen was randomized for both groups.
Lead I 1 of the electrocardiogram, oesophageal temperature and arterial pressure were monitored continuously. Arterial blood gases and serum sodium and potassium were determined during control, during the peak pressure response from epinephrine infusion and every 30 minutes for the rest of the study. Epinephrine (5 lag/ml) was infused at a rate of I lag" kg-~ -min -~ up to ten minutes. The persistence of three or more consecutive dysrhythmic beats was used as the endpoint of the epinephrine arrhythmogenic dose. Arte='ial blood gases showed minimal changes in both groups during the course of the experiment with Pao~ 24 -I-2.13 kPa ( 180 -I-16 torr), Paco2 4.8 + 0.4kPa (36 -I-3 torr) and cH § 43.65 • 0.14 nmol/1 (pH 7.36 + 0.07). Serum sodium did not change significantly during the experiment, but serum potassium increased to a peak concentration of 6.5 -I-0.4 mmol/l during the epinephrine infusion. The ventricular dysrhythmic dose of epinephrine was generally higher than the corresponding supraventricular dysrhythmic dose for each anaesthetic regimen for both groups. Th_..e arrhythmogenic doses for the ha_logenated-nitrous oxide anaesthesia group__s ~ere signihcantly h!gher than for th e narcodcn~trous oxide groups; however, the incidence of ventricular arrhythmias was greater in the halogenated-nitrous oxide groups (20 of 24 vs 20 of 267 48), The incidence of ventricula," arrhythmias was less in the methoxyflurane-n[trous oxide group (4/8) than in the halothane-nitrous oxide (8]8) or enfiurane-nitrous oxide (8/8) groups. Ventricular tachycardia and ventricular fibrillation occurred in live of eight in Ihe halothane group, three of eight in the enfturane group and in none of the eight in the methoxyflurane group, compared with an occurrence of one out of 48 epinephrine challenges in the narcotic-nitrous oxide groups. These results suggest that anaesthesia with narcotics or methoxyflurane with nitrous oxide and relaxants may stabilize the heart against serious epinephrine-induced ventricular dysrhythmias better than anaesthesia with halogenated inhalation agents, nitrous oxide and relaxant.
RI~SUM~
Cette Etude porte sur les dysrythmies provoquEes par I'EpinEphrine sur 16 chJens de race commune anesthesias aux halogEnEs et aux narcotiques. Un premier groupe de huit animaux a ,e~:u de l'halothane, de I'enflurane ou du mEthoxyflurane h une concentration Equivalente 1.2 fois la concentration alvEolaire minimale. alors que le deuxiEme groupe recevail de la morphine ~ la dose de Iet 2 rag. kg -I, du fenlanyl ;~l 0,01 et 0,02 rag. kg -~ ou de la mEp6ridine 10 et 20 mg. kg -n, Du protoxyde d'azote et de Foxyg~:ne ~ 50 pour cent ainsi que du pancuronium ont EtE administr6s aux deux g,oupes avec les produits mentionnEs. Chacun des animaux a EtE EtudiE trois fois mais jamais plus d'une fois pal" semaine et un seul produit a ErE employE par seance. L'ordre d'administration des agents a ErE randomisE pour les deux groupes. La derivation II de I'Electrocardiogramme, la temperature 0esophagienne et la pression artErielle ont 6t6 suivis de fa~;on continuelle. On a analyse les gaz du sang ainsi que la concentration du sodium et du potassium pendant la pEriode de contrfle, pendant I'infusion d'6pin~ph='ine et "b. toutes les trente minutesjusqu'h la fin de rEtude. Une solution d'EpinEphrine (5 lag/ml) a EtE perfusee h ta vitesse de I lag-kg -t 9 min -~ pendant dix minutes ou moins. Le temps d'arrEt de la perfusion a EtE dEterminE par la persistanee de trois battcments dysrythmiques ou plus. Les gaz du sang et le sodium ont EtE peu modifies pendant I'expErience alors que le potassium s'Elevait b. une concentration de 6.5 ___ 0.4 mmol/t au cours de la perfussion. Dans les deux groupes d'animaux, la dose d'EpinEphrine requise pour pro-
